Healthcare provider profile · identity verified

Wanda J Starling, MD

Family Practice · LANDRUM, SC · NPI 1760475057

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	317	34
Lisinopril	Lisinopril	310	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	305	39
Levothyroxine Sodium	Levothyroxine Sodium	269	47
Amlodipine Besylate	Amlodipine Besylate	211	38
Omeprazole	Omeprazole	199	32
Atorvastatin Calcium	Atorvastatin Calcium	191	38
Albuterol Sulfate Hfa	Albuterol Sulfate	156	35
Metformin Hcl	Metformin Hcl	111	23
Diazepam	Diazepam	101	14
Hydrochlorothiazide	Hydrochlorothiazide	93	17
Prednisone	Prednisone	93	45
Metoprolol Tartrate	Metoprolol Tartrate	90	20
Carvedilol	Carvedilol	89	18
Losartan Potassium	Losartan Potassium	88	25
Gabapentin	Gabapentin	84	20
Lorazepam	Lorazepam	82	15
Venlafaxine Hcl Er	Venlafaxine Hcl	82	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	81	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	72	suppressed
Montelukast Sodium	Montelukast Sodium	72	18
Allopurinol	Allopurinol	70	17
Furosemide	Furosemide	67	12
Oxycodone Hcl	Oxycodone Hcl	64	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	11
Azithromycin	Azithromycin	61	41
Simvastatin	Simvastatin	61	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	58	13
Tramadol Hcl	Tramadol Hcl	56	suppressed
Trazodone Hcl	Trazodone Hcl	56	14
Citalopram Hbr	Citalopram Hydrobromide	55	suppressed
Meloxicam	Meloxicam	54	suppressed
Ibuprofen	Ibuprofen	52	15
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Clonazepam	Clonazepam	49	suppressed
Diclofenac Sodium	Diclofenac Sodium	49	suppressed
Amoxicillin	Amoxicillin	47	36
Glimepiride	Glimepiride	45	suppressed
Famotidine	Famotidine	44	suppressed
Glipizide	Glipizide	44	11
Pantoprazole Sodium	Pantoprazole Sodium	43	11
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Metoprolol Succinate	Metoprolol Succinate	39	suppressed
Celecoxib	Celecoxib	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Ozempic	Semaglutide	38	suppressed
Spironolactone	Spironolactone	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Estradiol	Estradiol	35	suppressed
Meclizine Hcl	Meclizine Hcl	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Fenofibrate	Fenofibrate,micronized	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Acyclovir	Acyclovir	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	17
Bupropion Xl	Bupropion Hcl	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	13
Topiramate	Topiramate	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	22
Mirtazapine	Mirtazapine	27	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Naproxen	Naproxen	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	22	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	22	suppressed
Nystatin	Nystatin	22	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	14
Aripiprazole	Aripiprazole	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	11
Verapamil Er	Verapamil Hcl	17	suppressed
Ramipril	Ramipril	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Eliquis	Apixaban	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Betaxolol Hcl	Betaxolol Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Temazepam	Temazepam	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Qulipta	Atogepant	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error